In 2001 the only accepted treatment for HPV-related lesions is removal or eradication. Since the incidence of latent and recurrent infections is high, the eradication of HPV is not always 100% effective. It is essential to be aware that HPV is a sexually transmitted disease and women must engage in safe sex practices to decrease the risk of spreading the virus or becoming re-infected. The development of an HPV vaccine that would render individuals resistant to infection by at least some of the high-risk HPV types is a matter of considerable interest. It is possible that by 2010 such a vaccine will be available.
Cuzick J. "Human papillomavirus testing for primary cervical cancer screening." JAMA 283 (January 2000):108-9
Cox J.T. "Evaluating the role of HPV testing for women with equivocal Papanicolaou test findings." JAMA 281 (May 1999):1645-7.